Citadel Advisors
SRGA

Citadel Advisors’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Citadel Advisors’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25,840
Closed -$4.73K – 15648
2023
Q2 		$4.73K Sell
25,840
-8,790
-25% -$8.43K ﹤0.01% 13572
2023
Q1 		$55.4K Buy
+34,630
New +$70.4K ﹤0.01% 12027
2022
Q3 		– Sell
-11,631
Closed -$40K – 14302
2022
Q2 		$40K Buy
11,631
+2,443
+27% +$13.5K ﹤0.01% 12071
2022
Q1 		$83K Sell
9,188
-2,463
-21% -$37.4K ﹤0.01% 12459
2021
Q4 		$250K Buy
11,651
+3,321
+40% +$88.8K ﹤0.01% 11361
2021
Q3 		$272K Buy
8,330
+4,613
+124% +$169K ﹤0.01% 11274
2021
Q2 		$155K Buy
3,717
+729
+24% +$37.3K ﹤0.01% 12474
2021
Q1 		$195K Buy
+2,988
New +$208K ﹤0.01% 11739
2020
Q2 		– Sell
-2,528
Closed -$130K – 10769
2020
Q1 		$130K Buy
2,528
+763
+43% +$79.8K ﹤0.01% 8419
2019
Q4 		$145K Sell
1,765
-2,159
-55% -$151K ﹤0.01% 8385
2019
Q3 		$336K Sell
3,924
-419
-10% -$44.7K ﹤0.01% 7403
2019
Q2 		$554K Buy
+4,343
New +$625K ﹤0.01% 6663
2019
Q1 		– Sell
-769
Closed -$85K – 10109
2018
Q4 		$85K Sell
769
-417
-35% -$54.3K ﹤0.01% 8316
2018
Q3 		$160K Buy
1,186
+492
+71% +$67.8K ﹤0.01% 8351
2018
Q2 		$95K Sell
694
-244
-26% -$33.6K ﹤0.01% 8264
2018
Q1 		$130K Buy
+938
New +$128K ﹤0.01% 7612
2017
Q4 		– Sell
-893
Closed -$122K – 8609
2017
Q3 		$122K Buy
893
+412
+86% +$62.2K ﹤0.01% 6963
2017
Q2 		$84K Buy
+481
New +$68.4K ﹤0.01% 6969
2016
Q3 		– Sell
-364
Closed -$39K – 7962
2016
Q2 		$39K Sell
364
-797
-69% -$93.3K ﹤0.01% 6459
2016
Q1 		$139K Sell
1,161
-1,339
-54% -$141K ﹤0.01% 5877
2015
Q4 		$298K Sell
2,500
-3,498
-58% -$451K ﹤0.01% 5230
2015
Q3 		$1.02M Sell
5,998
-2,541
-30% -$487K ﹤0.01% 3788
2015
Q2 		$1.66M Buy
8,539
+615
+8% +$114K ﹤0.01% 3286
2015
Q1 		$1.18M Buy
7,924
+1,865
+31% +$284K ﹤0.01% 3736
2014
Q4 		$945K Buy
6,059
+2,715
+81% +$391K ﹤0.01% 3838
2014
Q3 		$479K Buy
+3,344
New +$485K ﹤0.01% 4675
2013
Q4 		– Sell
-2,075
Closed -$233K – 7225
2013
Q3 		$233K Buy
2,075
+951
+85% +$108K ﹤0.01% 4622
2013
Q2 		$127K Buy
+1,124
New +$137K ﹤0.01% 5042

Other funds holding SRGA

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
WWP
WR Wealth Planners Columbia, Missouri $311M AUM 18.22% 1-Year Est. Return

Citadel Advisors's SRGA Position: Q3 2023 in Review

Citadel Advisors sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2023, closing a stake of 25,840 shares — an estimated $4.73K sold.

Citadel Advisors first reported a position in SRGA in Q2 2013 and held it in 28 quarters. The position peaked at $1.66M in Q2 2015. 4 funds tracked by Wall St. Rank hold SRGA as of Q3 2023.

  • Citadel Advisors reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 25,840 Surgalign Holdings, Inc. Common Stock shares in Q3 2023, an estimated $4.73K.
  • Citadel Advisors first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 28 quarters.
  • Citadel Advisors's Surgalign Holdings, Inc. Common Stock position peaked at $1.66M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.